Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rein Therapeutics (RNTX) Prepaid Assets (2016 - 2025)

Rein Therapeutics filings provide 10 years of Prepaid Assets readings, the most recent being $230000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets rose 98.28% year-over-year to $230000.0, compared with a TTM value of $230000.0 through Dec 2025, up 98.28%, and an annual FY2025 reading of $230000.0, up 98.28% over the prior year.
  • Prepaid Assets hit $230000.0 in Q4 2025 for Rein Therapeutics, down from $997000.0 in the prior quarter.
  • The five-year high for Prepaid Assets was $2.2 million in Q4 2021, with the low at $39000.0 in Q1 2025.
  • Median Prepaid Assets over the past 5 years was $698000.0 (2023), compared with a mean of $841250.0.
  • The largest YoY upside for Prepaid Assets was 295.63% in 2025 against a maximum downside of 94.4% in 2025.
  • Year by year, Prepaid Assets stood at $2.2 million in 2021, then plummeted by 72.69% to $606000.0 in 2022, then crashed by 65.84% to $207000.0 in 2023, then crashed by 43.96% to $116000.0 in 2024, then soared by 98.28% to $230000.0 in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $230000.0, $997000.0, and $880000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.